eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | metabolic syndrome x |
| Comorbidity | C0011860|type 2 diabetes mellitus |
| Sentences | 25 |
| PubMedID- 21448316 | The identification and clinical management of the high-risk groups will contribute significantly to metabolic syndrome prevention in patients with type 2 diabetes mellitus. |
| PubMedID- 21089455 | [cardiac autonomous neuropathy and metabolic syndrome in patients with type 2 diabetes mellitus]. |
| PubMedID- 21936688 | metabolic syndrome (mets) is associated with development of type 2 diabetes mellitus and increased risk for cardiovascular disease. |
| PubMedID- 25760026 | Insulin resistance is a common pathological state found in the metabolic syndromeassociated with obesity and type 2 diabetes mellitus, in which target tissues fail torespond properly to physiologic insulin levels (5,7). |
| PubMedID- 22922310 | type 2 diabetes mellitus has been associated with obesity, metabolic syndrome, cardiovascular diseases and cancer. |
| PubMedID- 21498915 | type 2 diabetes mellitus (t2dm) associated with metabolic syndrome (mets) represents a high risk of cardiovascular disease. |
| PubMedID- 22474593 | At present, little data exist about incidence and the risk factors associated with metabolic syndrome (mets) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 22669833 | Relationship between serum testosterone levels and features of the metabolic syndrome defining criteria in patients with type 2 diabetes mellitus. |
| PubMedID- 23115071 | Introduction: at present, little data exists about the incidence of, and the risk factors associated with, metabolic syndrome (mets) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 25737976 | Aims and objectives: to study the prevalence of the metabolic syndrome in type 2 diabetes mellitus. |
| PubMedID- 25782325 | [clinical evaluation of the influence of certain initial status parameters on the development of type 2 diabetes mellitus in patients with metabolic syndrome]. |
| PubMedID- 20197633 | Small, dense ldl and high-sensitivity c-reactive protein (hs-crp) in metabolic syndrome with type 2 diabetes mellitus. |
| PubMedID- 24589612 | Objective: to study the correlation between adipocytokines levels and metabolic syndrome (ms) in patients with newly diagnosed type 2 diabetes mellitus (t2dm). |
| PubMedID- 24601861 | This study aims to assess the prevalence of the components of the metabolic syndrome in type 2 diabetes mellitus (t2dm) patients using the international diabetes federation (idf) worldwide definition. |
| PubMedID- 21409896 | The objective of the study was to observe the frequency of metabolic syndrome (mets) in patients with type 2 diabetes mellitus and study the relationship of insulin resistance with the metabolic syndrome and its different clinical parameters. |
| PubMedID- 26097823 | Prevalence of metabolic syndrome in type 2 diabetes mellitus patients. |
| PubMedID- 25561880 | Aim: the dietary contents have a very important role in the management of metabolic syndrome along with type 2 diabetes mellitus (t2dm). |
| PubMedID- 23728331 | type 2 diabetes mellitus with metabolic syndrome developed at 30 weeks of age, and the body weights and plasma insulin levels of oletf rats at 60 weeks of age were lower than those of normal rats. |
| PubMedID- 25657309 | metabolic syndrome individuals with and without type 2 diabetes mellitus present generalized vascular dysfunction: cross-sectional study. |
| PubMedID- 20142634 | This study was performed to establish whether only 2 sessions per week of combined aerobic and resistance exercise are enough to reduce glycated hemoglobin (hba(1c)) and to induce changes in skeletal muscle gene expression in type 2 diabetes mellitus (dm2) subjects with metabolic syndrome. |
| PubMedID- 22809366 | In addition, fatty liver is a manifestation of metabolic syndrome, and is associated with obesity, type 2 diabetes mellitus (t2dm), and hypertriglyceridemia [11]. |
| PubMedID- 22389088 | The metabolic syndrome is often associated with type 2 diabetes mellitus, dyslipidemia, atherosclerosis, hypertension, steatosis of the liver and other organs, as well as hypertension, type 2 diabetes mellitus, and atherosclerosis. |
| PubMedID- 21993838 | Thus, pai-1 plays a critical role in the insulin resistance syndrome, which leads to type 2 diabetes mellitus, and is associated with its side effects such as an increased risk of diabetic nephropathy, atherosclerotic cardiovascular disease and others. |
| PubMedID- 25054102 | Prevalence, components and associated demographic and lifestyle factors of the metabolic syndrome in type 2 diabetes mellitus. |
| PubMedID- 24171882 | Prevalence of metabolic syndrome in type 2 diabetes mellitus using ncep-atpiii, idf and who definition and its agreement in gwalior chambal region of central india. |
Page: 1